Follicular Lymphoma CD20 positive Untreated
Item
diagnosis of cd20+, follicular lymphoma that has not been treated
boolean
C0024301 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
CD20 Tumor immunophenotyping status | Lymphoma, Follicular
Item
cd20-immunophenotyping of tumor to document b-cell follicular lymphoma
boolean
C0054946 (UMLS CUI [1,1])
C1300074 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2])
Disease Ann Arbor lymphoma staging system | Bulky Disease Lesion size
Item
stage ii disease with bulky disease (≥ 7cm lesion), stage iii, or stage iv disease
boolean
C0012634 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
C1511341 (UMLS CUI [2,1])
C0449453 (UMLS CUI [2,2])
Disease Treatment required for
Item
disease that requires treatment based on the investigator's opinion (e.g., meets gelf criteria)
boolean
C0012634 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Measurable lesion | Lesion size Dimension Quantity
Item
at least one measurable lesion that is > 1.5 cm in at least one dimension
boolean
C1513041 (UMLS CUI [1])
C0449453 (UMLS CUI [2,1])
C0439534 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
ECOG performance status | Karnofsky Performance Status
Item
eastern cooperative oncology group (ecog) performance status <=2 (corresponds to karnofsky performance status [kps] >=60%)
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
Systemic therapy Lymphoma | Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Investigational New Drugs | Radioimmunotherapy
Item
received systemic treatment for lymphoma such as chemotherapy, immunotherapy, radiotherapy, investigational agents, or radioimmunotherapy.
boolean
C1515119 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0013230 (UMLS CUI [5])
C0085101 (UMLS CUI [6])
Transformation Lymphoma Subtype Aggressive | Transformation Follicular Lymphoma Grade
Item
clinical evidence of transformation to a more aggressive subtype of lymphoma or grade 3b follicular lymphoma
boolean
C0040682 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,3])
C0580822 (UMLS CUI [1,4])
C0040682 (UMLS CUI [2,1])
C0024301 (UMLS CUI [2,2])
C0441800 (UMLS CUI [2,3])
Severe allergic reaction Monoclonal Antibody Therapy | Anaphylactic reaction Severe Monoclonal Antibody Therapy | Severe allergic reaction Murine protein | Anaphylactic reaction Severe Murine protein | Hypersensitivity Investigational New Drugs
Item
severe allergic or anaphylactic reaction to any monoclonal antibody therapy, murine protein, or known hypersensitivity to any of the study drugs
boolean
C2220378 (UMLS CUI [1,1])
C0279694 (UMLS CUI [1,2])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0279694 (UMLS CUI [2,3])
C2220378 (UMLS CUI [3,1])
C1699668 (UMLS CUI [3,2])
C0002792 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C1699668 (UMLS CUI [4,3])
C0020517 (UMLS CUI [5,1])
C0013230 (UMLS CUI [5,2])
Allogeneic Hematopoietic Stem Cell Transplantation
Item
prior allogeneic hematopoietic stem cell transplant
boolean
C1705576 (UMLS CUI [1])
Hepatitis B | Hepatitis C | Hepatitis B, Chronic | Hepatitis C, Chronic
Item
prior, current or chronic hepatitis b or hepatitis c infection
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0524909 (UMLS CUI [3])
C0524910 (UMLS CUI [4])
HIV Infection | HTLV-I Infection
Item
human immunodeficiency virus (hiv) infection or human t cell lymphotropic virus 1 (htlv-1) infection
boolean
C0019693 (UMLS CUI [1])
C0020097 (UMLS CUI [2])